Cannabis in the Digestive & Gastrointestinal Tract
$49.00
This curriculum was developed in 2021 and reflects the scientific and clinical understanding available at that time. As this field continues to advance, we are preparing a comprehensive curriculum update incorporating the latest research and best practices. The new program is expected to launch in Q4 2026. Subscribe to receive updates and early access information.
Timna Naftali, MD discusses the role of cannabinoids on diseases affecting the digestive and gastrointestinal tract. Upon completion, participants will have a strong overview of the current literature on the potential applications of cannabis for the treatment of irritable bowel disease, nausea and vomiting, Crohn’s disease, and ulcerative colitis. Dr. Naftali also highlights future potential for research in this area.
*Includes a certificate of completion
